These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 9016340)
21. Regulation of DARPP-32 phosphorylation by three distinct dopamine D1-like receptor signaling pathways in the neostriatum. Kuroiwa M; Bateup HS; Shuto T; Higashi H; Tanaka M; Nishi A J Neurochem; 2008 Nov; 107(4):1014-26. PubMed ID: 18823371 [TBL] [Abstract][Full Text] [Related]
22. Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain. Undie AS; Friedman E J Pharmacol Exp Ther; 1990 Jun; 253(3):987-92. PubMed ID: 1972756 [TBL] [Abstract][Full Text] [Related]
23. The dopamine D1D receptor. Cloning and characterization of three pharmacologically distinct D1-like receptors from Gallus domesticus. Demchyshyn LL; Sugamori KS; Lee FJ; Hamadanizadeh SA; Niznik HB J Biol Chem; 1995 Feb; 270(8):4005-12. PubMed ID: 7876148 [TBL] [Abstract][Full Text] [Related]
24. Characteristics of stably expressed human dopamine D1a and D1b receptors: atypical behavior of the dopamine D1b receptor. Pedersen UB; Norby B; Jensen AA; Schiødt M; Hansen A; Suhr-Jessen P; Scheideler M; Thastrup O; Andersen PH Eur J Pharmacol; 1994 Mar; 267(1):85-93. PubMed ID: 8206133 [TBL] [Abstract][Full Text] [Related]
25. Relationship between dopamine agonist stimulation of inositol phosphate formation and cytidine diphosphate-diacylglycerol accumulation in brain slices. Undie AS Brain Res; 1999 Jan; 816(2):286-94. PubMed ID: 9878788 [TBL] [Abstract][Full Text] [Related]
27. Rosiglitazone restores G-protein coupling, recruitment, and function of renal dopamine D1A receptor in obese Zucker rats. Trivedi M; Marwaha A; Lokhandwala M Hypertension; 2004 Feb; 43(2):376-82. PubMed ID: 14718363 [TBL] [Abstract][Full Text] [Related]
28. Modulatory actions of dopamine on NMDA receptor-mediated responses are reduced in D1A-deficient mutant mice. Levine MS; Altemus KL; Cepeda C; Cromwell HC; Crawford C; Ariano MA; Drago J; Sibley DR; Westphal H J Neurosci; 1996 Sep; 16(18):5870-82. PubMed ID: 8795639 [TBL] [Abstract][Full Text] [Related]
29. The cytoplasmic tail of the D1A receptor subtype: identification of specific domains controlling dopamine cellular responsiveness. Chaar ZY; Jackson A; Tiberi M J Neurochem; 2001 Dec; 79(5):1047-58. PubMed ID: 11739618 [TBL] [Abstract][Full Text] [Related]
31. Modulation of dopamine D1 receptor signaling by adenosine A1 receptors in Sf9 cells requires expression of Gi proteins. Uustare A; Reinart R; Rinken A Neurosci Lett; 2006 Oct; 406(3):169-73. PubMed ID: 16935419 [TBL] [Abstract][Full Text] [Related]
32. Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase. Deveney AM; Waddington JL Br J Pharmacol; 1995 Oct; 116(3):2120-6. PubMed ID: 8640354 [TBL] [Abstract][Full Text] [Related]
33. mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase. Yoshimura M; Ikeda H; Tabakoff B Mol Pharmacol; 1996 Jul; 50(1):43-51. PubMed ID: 8700117 [TBL] [Abstract][Full Text] [Related]
34. A comparison of the locomotor stimulant effects of D1-like receptor agonists in mice. Desai RI; Terry P; Katz JL Pharmacol Biochem Behav; 2005 Aug; 81(4):843-8. PubMed ID: 16000217 [TBL] [Abstract][Full Text] [Related]
35. Diminished natriuretic response to dopamine in old rats is due to an impaired D1-like receptor-signaling pathway. Beheray S; Kansra V; Hussain T; Lokhandwala MF Kidney Int; 2000 Aug; 58(2):712-20. PubMed ID: 10916094 [TBL] [Abstract][Full Text] [Related]
36. A novel role for dopamine: inhibition of muscarinic cholinergic-stimulated phosphoinositide hydrolysis in rat brain cortical membranes. Wallace MA; Claro E Neurosci Lett; 1990 Mar; 110(1-2):155-61. PubMed ID: 2158015 [TBL] [Abstract][Full Text] [Related]
37. D1A, D1B, and D1C dopamine receptors from Xenopus laevis. Sugamori KS; Demchyshyn LL; Chung M; Niznik HB Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10536-40. PubMed ID: 7937989 [TBL] [Abstract][Full Text] [Related]
38. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation. Hess EJ; Albers LJ; Le H; Creese I J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223 [TBL] [Abstract][Full Text] [Related]
39. Ethological resolution of behavioural topography and D1-like versus D2-like agonist responses in congenic D5 dopamine receptor mutants: identification of D5:D2-like interactions. O'Sullivan GJ; Kinsella A; Sibley DR; Tighe O; Croke DT; Waddington JL Synapse; 2005 Mar; 55(4):201-11. PubMed ID: 15668951 [TBL] [Abstract][Full Text] [Related]
40. Delineation of the structural basis for the activation properties of the dopamine D1 receptor subtypes. Iwasiow RM; Nantel MF; Tiberi M J Biol Chem; 1999 Nov; 274(45):31882-90. PubMed ID: 10542214 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]